These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 17494093)

  • 1. A complex, tissue-specific role for plasmin and its regulators in modulating fibrogenic activity.
    Cosgrove D
    Am J Physiol Renal Physiol; 2007 Jul; 293(1):F10-1. PubMed ID: 17494093
    [No Abstract]   [Full Text] [Related]  

  • 2. Regulation of gelatinase activity in mice with targeted inactivation of components of the plasminogen/plasmin system.
    Lijnen HR; Silence J; Lemmens G; Frederix L; Collen D
    Thromb Haemost; 1998 Jun; 79(6):1171-6. PubMed ID: 9657444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Requirement for receptor-bound urokinase in plasmin-dependent cellular conversion of latent TGF-beta to TGF-beta.
    Odekon LE; Blasi F; Rifkin DB
    J Cell Physiol; 1994 Mar; 158(3):398-407. PubMed ID: 8126064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urokinase-dependent cell surface proteolysis and cancer.
    Blasi F; Verde P
    Semin Cancer Biol; 1990 Apr; 1(2):117-26. PubMed ID: 2151734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasminogen activators and plasmin in lung cancer.
    Maksimowicz T; Gacko M; Chyczewska E; Chyczewski L; Myćko G; Worowski K
    Rocz Akad Med Bialymst; 1997; 42 Suppl 1():72-8. PubMed ID: 9337525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The biologic role of components of the plasminogen-plasmin system.
    Kwaan HC
    Prog Cardiovasc Dis; 1992; 34(5):309-16. PubMed ID: 1531879
    [No Abstract]   [Full Text] [Related]  

  • 7. Endogenous urokinase lacks antifibrotic activity during progressive renal injury.
    Yamaguchi I; Lopez-Guisa JM; Cai X; Collins SJ; Okamura DM; Eddy AA
    Am J Physiol Renal Physiol; 2007 Jul; 293(1):F12-9. PubMed ID: 17356128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of urokinase-type plasminogen activator or matrix metalloproteinases prevents cardiac injury and dysfunction during viral myocarditis.
    Heymans S; Pauschinger M; De Palma A; Kallwellis-Opara A; Rutschow S; Swinnen M; Vanhoutte D; Gao F; Torpai R; Baker AH; Padalko E; Neyts J; Schultheiss HP; Van de Werf F; Carmeliet P; Pinto YM
    Circulation; 2006 Aug; 114(6):565-73. PubMed ID: 16880329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed treatment with plasminogen activator inhibitor-1 decoys reduces tubulointerstitial fibrosis.
    Gonzalez J; Klein J; Chauhan SD; Neau E; Calise D; Nevoit C; Chaaya R; Miravete M; Delage C; Bascands JL; Schanstra JP; Buffin-Meyer B
    Exp Biol Med (Maywood); 2009 Dec; 234(12):1511-8. PubMed ID: 19934371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmin(ogen) promotes renal interstitial fibrosis by promoting epithelial-to-mesenchymal transition: role of plasmin-activated signals.
    Zhang G; Kernan KA; Collins SJ; Cai X; López-Guisa JM; Degen JL; Shvil Y; Eddy AA
    J Am Soc Nephrol; 2007 Mar; 18(3):846-59. PubMed ID: 17267741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants.
    Mazzieri R; Masiero L; Zanetta L; Monea S; Onisto M; Garbisa S; Mignatti P
    EMBO J; 1997 May; 16(9):2319-32. PubMed ID: 9171346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of plasminogen-plasmin system in cancer.
    Kwaan HC; McMahon B
    Cancer Treat Res; 2009; 148():43-66. PubMed ID: 19377918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene targeting and gene transfer studies of the plasminogen/plasmin system: implications in thrombosis, hemostasis, neointima formation, and atherosclerosis.
    Carmeliet P; Collen D
    FASEB J; 1995 Jul; 9(10):934-8. PubMed ID: 7615162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The plasminogen activator inhibitor system in bone cell function.
    Allan EH; Martin TJ
    Clin Orthop Relat Res; 1995 Apr; (313):54-63. PubMed ID: 7641498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms of protease-mediated tumor invasiveness.
    Blasi F
    J Surg Oncol Suppl; 1993; 3():21-3. PubMed ID: 8503981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel laminin 5 gamma 2-chain fragments potentiating the limbal epithelial cell outgrowth on amniotic membrane.
    Cheng CY; Sun CC; Yu WH; Hsieh HL; Ma DH; Pang JH; Yang CM
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4631-9. PubMed ID: 19420329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urokinase-type plasminogen activator regulates cranial neural crest cell migration in vitro.
    Agrawal M; Brauer PR
    Dev Dyn; 1996 Nov; 207(3):281-90. PubMed ID: 8922527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of urokinase-type plasminogen activator (uPA) and transforming growth factor beta 1 (TGFbeta1) in muscle regeneration.
    Philippou A; Maridaki M; Koutsilieris M
    In Vivo; 2008; 22(6):735-50. PubMed ID: 19181000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane.
    Liotta LA; Goldfarb RH; Brundage R; Siegal GP; Terranova V; Garbisa S
    Cancer Res; 1981 Nov; 41(11 Pt 1):4629-36. PubMed ID: 6458354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulated localization confers multiple functions on the protease urokinase plasminogen activator.
    Wells JM; Strickland S
    J Cell Physiol; 1997 May; 171(2):217-25. PubMed ID: 9130470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.